DSM and Sanquin sign manufacturing agreement for factor IX antibody

10/24/2013 | Genetic Engineering & Biotechnology News

Sanquin Blood Supply Foundation and DSM Pharmaceutical Products have signed a commercial manufacturing agreement to produce a monoclonal antibody for the recovery and purification of coagulation factor IX from human blood. Production will take place at a DSM Biologics facility in the Netherlands.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA